Testing a new drug for leprosy: clofazimine and its precursors in Ireland and Nigeria, 1944-1966

In Wenzel Geissler & Catherine Molyneux (eds.), Evidence, Ethos and Experiment: The Anthropology and History of Medical Research in Africa. Berghahn Books. pp. 125 (2011)
  Copy   BIBTEX

Abstract

This article has no associated abstract. (fix it)

Categories

Keywords

Reprint years

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 91,752

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

My notes

Similar books and articles

Drug testing and corporate responsibility: The “ought implies can” argument. [REVIEW]Jennifer Moore - 1989 - Journal of Business Ethics 8 (4):279 - 287.
Drug testing and the right to privacy: Arguing the ethics of workplace drug testing. [REVIEW]Michael Cranford - 1998 - Journal of Business Ethics 17 (16):1805-1815.
Ethics of research involving mandatory drug testing of high school athletes in oregon.Adil E. Shamoo & Jonathan D. Moreno - 2004 - American Journal of Bioethics 4 (1):25 – 31.
Drug testing and productivity.Nicholas J. Caste - 1992 - Journal of Business Ethics 11 (4):301 - 306.
生命的哲学 ‐后基因时代药物筛选策略与传统中药学理论.Xiao Ming Wang - 2008 - Proceedings of the Xxii World Congress of Philosophy 44:139-142.
Ethical considerations in the testing of biopharmaceuticals for adventitious agents.Richard S. Woodward - 1995 - Science and Engineering Ethics 1 (3):273-282.
Judgments of the fairness of using performance enhancing drugs.John Sabini & John Monterosso - 2005 - Ethics and Behavior 15 (1):81 – 94.
Limitations on the Moral Permissibility of Employee Drug Testing.John R. Rowan - 2000 - Business and Professional Ethics Journal 19 (2):69-82.
Democracy in a multireligious and cultural setting: The nigerian context.Marinus Iwuchukwu - 2003 - World Futures 59 (5):381 – 390.
Drug Testing: A Bad Investment.Lewis L. Maltby - 2001 - Business Ethics 15 (2):7-7.
Integrating research and development: the emergence of rational drug design in the pharmaceutical industry.Matthias Adam - 2005 - Studies in History and Philosophy of Science Part C: Studies in History and Philosophy of Biological and Biomedical Sciences 36 (3):513-537.

Analytics

Added to PP
2011-05-22

Downloads
11 (#1,133,540)

6 months
1 (#1,464,097)

Historical graph of downloads
How can I increase my downloads?

Citations of this work

No citations found.

Add more citations

References found in this work

No references found.

Add more references